Revenue,
USD 1.70 Bn
Forecast Year,
USD 4.41 Bn
CAGR, 2025 -
10.00%
Report Coverage
Worldwide
Intranasal Drug Delivery Devices Market Size Analysis
Intranasal Drug Delivery Devices Market Size By System 2024 to 2034 (USD )
| System | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Single-dose | 0.78 | 0.86 | 0.95 | 1.04 | 1.15 | 1.26 | 1.39 | 1.53 | 1.68 | 1.85 | 2.03 |
| Multi-dose | 0.92 | 1.01 | 1.11 | 1.22 | 1.34 | 1.48 | 1.63 | 1.79 | 1.97 | 2.16 | 2.38 |
Intranasal Drug Delivery Devices Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pain Management | 0.44 | 0.49 | 0.54 | 0.59 | 0.65 | 0.72 | 0.80 | 0.88 | 0.97 | 1.07 | 1.18 |
| Vaccines | 0.37 | 0.41 | 0.45 | 0.50 | 0.55 | 0.60 | 0.66 | 0.73 | 0.81 | 0.89 | 0.98 |
| Hormones | 0.31 | 0.33 | 0.36 | 0.39 | 0.43 | 0.46 | 0.50 | 0.55 | 0.59 | 0.64 | 0.70 |
| CNS | 0.31 | 0.34 | 0.37 | 0.41 | 0.46 | 0.51 | 0.56 | 0.62 | 0.69 | 0.76 | 0.84 |
| Others | 0.27 | 0.30 | 0.33 | 0.36 | 0.40 | 0.44 | 0.49 | 0.53 | 0.59 | 0.65 | 0.71 |
Intranasal Drug Delivery Devices Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 0.75 | 0.82 | 0.91 | 1.00 | 1.10 | 1.22 | 1.34 | 1.48 | 1.63 | 1.80 | 1.98 |
| Homecare | 0.54 | 0.60 | 0.66 | 0.73 | 0.80 | 0.89 | 0.98 | 1.08 | 1.19 | 1.31 | 1.45 |
| Clinics/Other | 0.41 | 0.45 | 0.49 | 0.53 | 0.58 | 0.63 | 0.69 | 0.75 | 0.82 | 0.90 | 0.98 |
Intranasal Drug Delivery Devices Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.61 | 0.67 | 0.74 | 0.81 | 0.90 | 0.99 | 1.09 | 1.19 | 1.31 | 1.44 | 1.59 |
| Europe | 0.48 | 0.52 | 0.58 | 0.63 | 0.70 | 0.77 | 0.85 | 0.93 | 1.02 | 1.13 | 1.24 |
| Asia Pacific | 0.49 | 0.54 | 0.59 | 0.64 | 0.70 | 0.77 | 0.84 | 0.91 | 1.00 | 1.09 | 1.19 |
| Latin America | 0.07 | 0.08 | 0.09 | 0.10 | 0.12 | 0.13 | 0.15 | 0.17 | 0.19 | 0.22 | 0.24 |
| Middle East & Africa | 0.05 | 0.06 | 0.06 | 0.07 | 0.08 | 0.09 | 0.10 | 0.11 | 0.12 | 0.13 | 0.15 |
Intranasal Drug Delivery Devices Market
Intranasal Drug Delivery Devices Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com